LEADIANT BIOSCIENCES

Class [005]
Pharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system and the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, namely, Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, encephalitis, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely, schizophrenia and psychoses; pharmaceutical preparations for the prevention and treatment of disorders of the immune system, namely, autoimmune diseases and disorders, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of disorders of the musculoskeletal system, namely, connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for the prevention and treatment of disorders of the genitourinary system, namely, urological diseases and disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology; pharmaceutical preparations for the treatment of nephrological disorders, namely, kidney diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and injuries, arthritis, rheumatoid arthritis, arthrosis, vasculitis, synovitis; pharmaceutical preparations for the treatment of rare diseases, namely, Neurotrophic Keratitis, Retinitis Pigmentosa, AIDS, SARS, West Nile virus, Tyrosinemia, rare lung diseases, lysosomal storage diseases; pharmaceutical preparations for the treatment of carnitine deficiency, administered by injection, orally by liquid solution and in tablet form; pharmaceutical preparations for the prevention and treatment of disorders in ophthalmology, in gastroenterological areas and for ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of tissue and organ transplantation rejection, stem cell transplantation rejection and for preventing viral infections in post-transplant patients; pharmaceutical preparations for use in dermatology, namely, for dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases, sunburn, rashes, sores, corns, calluses and acne, skin pigmentation; pharmaceutical preparations for use in hematology, namely, for treating blood disorders, thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for use in hematology, namely, antifungals; dietary supplements for animals, namely, supplements for general health and well being, vitamins, minerals and carnitine supplements; dietary supplements for humans, namely, supplements for general health and well being, vitamins, minerals and carnitine supplements.